# VENTRUS BIOSCIENCES INC: Form D filings

VENTRUS BIOSCIENCES INC, a biotechnology company in New York, NY, filed 3 Form D notices with the SEC in 2010. The latest, on May 24, 2010, reports $700,000 sold of a $750,000 offering to 8 investors.

Find out what VENTRUS BIOSCIENCES INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20VENTRUS%20BIOSCIENCES%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=VENTRUS%20BIOSCIENCES%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fventrus-biosciences-inc-1426800)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20VENTRUS%20BIOSCIENCES%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=VENTRUS%20BIOSCIENCES%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fventrus-biosciences-inc-1426800)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 787 7TH AVENUE, 48TH FLOOR, New York, NY, 10019
- Phone: (212) 554-4388
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2005
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1426800

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 24, 2010 | New notice | $750,000 | $700,000 | $50,000 | 8 | May 6, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1426800/000142680010000005/0001426800-10-000005-index.htm) |
| Apr 26, 2010 | Amendment | $4,500,000 | $2,725,000 | $1,775,000 | 44 | Feb 26, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1426800/000142680010000004/0001426800-10-000004-index.htm) |
| Mar 12, 2010 | New notice | $4,500,000 | $2,150,000 | $2,350,000 | 35 | Feb 26, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1426800/000142680010000003/0001426800-10-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Joseph Felder | Director |  |
| Thom Rowland | Executive Officer, Director |  |

## Other biotechnology companies in New York that filed recently

- [Swep Bio, Inc.](https://specstream.ai/data/form-d/company/swep-bio-inc-2159106) $2.5 million · Oct 29, 2026
- [Hypercell Technologies Inc.](https://specstream.ai/data/form-d/company/hypercell-technologies-inc-1882357) $3 million · Oct 14, 2026
- [CAD Therapeutics, Inc.](https://specstream.ai/data/form-d/company/cad-therapeutics-inc-2157566) $4 million · Oct 2, 2026
- [Vicora, Inc.](https://specstream.ai/data/form-d/company/vicora-inc-2091847) $2.3 million · Sep 18, 2026
- [GevRx Nutraceuticals, Inc.](https://specstream.ai/data/form-d/company/gevrx-nutraceuticals-inc-2156105) $300,000 · Sep 18, 2026
- [Episteme Prognostics, Inc.](https://specstream.ai/data/form-d/company/episteme-prognostics-inc-1902402) $5.1 million · Sep 4, 2026

[Every Form D from the week of May 24, 2010](https://specstream.ai/data/form-d/week/2010-05-24) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what VENTRUS BIOSCIENCES INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).